Model Predicts Progression Risk for Rare Type of Lymphoma
FRIDAY, May 3, 2019 -- A publicly available model can identify patients with asymptomatic Waldenstr öm macroglobulinemia (AWM) at high risk for progression, according to a study published online April 16 in the Journal of Clinical Oncology.
Mark...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Lymphoma | Macroglobulinemia | Pharmaceuticals | Study | Waldenstrom's Macroglobulinemia